Pigeon Corporation
Pigeon Corporation (PGENY) Stock Competitors & Peer Comparison
See (PGENY) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PGENY | $2.53 | +0.00% | 1.2B | 23.00 | $0.11 | +3.41% |
| LRLCF | $429.64 | +4.28% | 228.8B | 32.28 | $13.31 | +1.84% |
| LRLCY | $80.79 | -2.01% | 215.3B | 30.33 | $2.66 | +1.96% |
| UNLYF | $64.20 | -1.31% | 140.3B | 21.84 | $2.94 | +3.72% |
| RBGLY | $14.12 | -0.07% | 49.5B | 28.18 | $0.50 | +8.38% |
| RBGPF | $74.17 | +0.00% | 47.8B | 29.20 | $2.54 | +8.43% |
| HENOF | $96.58 | +0.00% | 40.5B | 16.71 | $5.78 | +2.41% |
| HENOY | $20.06 | -1.96% | 33.6B | 13.91 | $1.44 | +2.86% |
| HENKY | $18.78 | -2.19% | 32.3B | 12.95 | $1.45 | +2.08% |
| HELKF | $76.90 | +0.00% | 32.2B | 13.06 | $5.89 | +3.00% |
Stock Comparison
PGENY vs LRLCF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, LRLCF has a market cap of 228.8B. Regarding current trading prices, PGENY is priced at $2.53, while LRLCF trades at $429.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas LRLCF's P/E ratio is 32.28. In terms of profitability, PGENY's ROE is +0.11%, compared to LRLCF's ROE of +0.19%. Regarding short-term risk, PGENY is less volatile compared to LRLCF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check LRLCF's competition here
PGENY vs LRLCY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, LRLCY has a market cap of 215.3B. Regarding current trading prices, PGENY is priced at $2.53, while LRLCY trades at $80.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas LRLCY's P/E ratio is 30.33. In terms of profitability, PGENY's ROE is +0.11%, compared to LRLCY's ROE of +0.18%. Regarding short-term risk, PGENY is less volatile compared to LRLCY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check LRLCY's competition here
PGENY vs UNLYF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, UNLYF has a market cap of 140.3B. Regarding current trading prices, PGENY is priced at $2.53, while UNLYF trades at $64.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas UNLYF's P/E ratio is 21.84. In terms of profitability, PGENY's ROE is +0.11%, compared to UNLYF's ROE of +0.37%. Regarding short-term risk, PGENY and UNLYF have similar daily volatility (0.00).Check UNLYF's competition here
PGENY vs RBGLY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, RBGLY has a market cap of 49.5B. Regarding current trading prices, PGENY is priced at $2.53, while RBGLY trades at $14.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas RBGLY's P/E ratio is 28.18. In terms of profitability, PGENY's ROE is +0.11%, compared to RBGLY's ROE of +0.45%. Regarding short-term risk, PGENY is less volatile compared to RBGLY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check RBGLY's competition here
PGENY vs RBGPF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, RBGPF has a market cap of 47.8B. Regarding current trading prices, PGENY is priced at $2.53, while RBGPF trades at $74.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas RBGPF's P/E ratio is 29.20. In terms of profitability, PGENY's ROE is +0.11%, compared to RBGPF's ROE of +0.45%. Regarding short-term risk, PGENY and RBGPF have similar daily volatility (0.00).Check RBGPF's competition here
PGENY vs HENOF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, HENOF has a market cap of 40.5B. Regarding current trading prices, PGENY is priced at $2.53, while HENOF trades at $96.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas HENOF's P/E ratio is 16.71. In terms of profitability, PGENY's ROE is +0.11%, compared to HENOF's ROE of +0.10%. Regarding short-term risk, PGENY is less volatile compared to HENOF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check HENOF's competition here
PGENY vs HENOY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, HENOY has a market cap of 33.6B. Regarding current trading prices, PGENY is priced at $2.53, while HENOY trades at $20.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas HENOY's P/E ratio is 13.91. In terms of profitability, PGENY's ROE is +0.11%, compared to HENOY's ROE of +0.10%. Regarding short-term risk, PGENY is less volatile compared to HENOY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check HENOY's competition here
PGENY vs HENKY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, HENKY has a market cap of 32.3B. Regarding current trading prices, PGENY is priced at $2.53, while HENKY trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas HENKY's P/E ratio is 12.95. In terms of profitability, PGENY's ROE is +0.11%, compared to HENKY's ROE of +0.10%. Regarding short-term risk, PGENY is less volatile compared to HENKY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check HENKY's competition here
PGENY vs HELKF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, HELKF has a market cap of 32.2B. Regarding current trading prices, PGENY is priced at $2.53, while HELKF trades at $76.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas HELKF's P/E ratio is 13.06. In terms of profitability, PGENY's ROE is +0.11%, compared to HELKF's ROE of +0.10%. Regarding short-term risk, PGENY and HELKF have similar daily volatility (0.00).Check HELKF's competition here
PGENY vs ETTYF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, ETTYF has a market cap of 20.3B. Regarding current trading prices, PGENY is priced at $2.53, while ETTYF trades at $28.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas ETTYF's P/E ratio is 13.99. In terms of profitability, PGENY's ROE is +0.11%, compared to ETTYF's ROE of +0.15%. Regarding short-term risk, PGENY is less volatile compared to ETTYF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check ETTYF's competition here
PGENY vs BDRFF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, BDRFF has a market cap of 19.7B. Regarding current trading prices, PGENY is priced at $2.53, while BDRFF trades at $90.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas BDRFF's P/E ratio is 18.24. In terms of profitability, PGENY's ROE is +0.11%, compared to BDRFF's ROE of +0.11%. Regarding short-term risk, PGENY is less volatile compared to BDRFF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check BDRFF's competition here
PGENY vs BDRFY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, BDRFY has a market cap of 19.7B. Regarding current trading prices, PGENY is priced at $2.53, while BDRFY trades at $17.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas BDRFY's P/E ratio is 18.06. In terms of profitability, PGENY's ROE is +0.11%, compared to BDRFY's ROE of +0.11%. Regarding short-term risk, PGENY is less volatile compared to BDRFY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check BDRFY's competition here
PGENY vs KAOCF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KAOCF has a market cap of 17.9B. Regarding current trading prices, PGENY is priced at $2.53, while KAOCF trades at $39.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KAOCF's P/E ratio is 24.00. In terms of profitability, PGENY's ROE is +0.11%, compared to KAOCF's ROE of +0.12%. Regarding short-term risk, PGENY is less volatile compared to KAOCF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check KAOCF's competition here
PGENY vs KAOOY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KAOOY has a market cap of 17.3B. Regarding current trading prices, PGENY is priced at $2.53, while KAOOY trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KAOOY's P/E ratio is 23.18. In terms of profitability, PGENY's ROE is +0.11%, compared to KAOOY's ROE of +0.12%. Regarding short-term risk, PGENY is less volatile compared to KAOOY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check KAOOY's competition here
PGENY vs UNICY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, UNICY has a market cap of 10B. Regarding current trading prices, PGENY is priced at $2.53, while UNICY trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas UNICY's P/E ratio is 26.23. In terms of profitability, PGENY's ROE is +0.11%, compared to UNICY's ROE of +0.08%. Regarding short-term risk, PGENY is less volatile compared to UNICY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check UNICY's competition here
PGENY vs UNCHF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, UNCHF has a market cap of 9.6B. Regarding current trading prices, PGENY is priced at $2.53, while UNCHF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas UNCHF's P/E ratio is 23.00. In terms of profitability, PGENY's ROE is +0.11%, compared to UNCHF's ROE of +0.08%. Regarding short-term risk, PGENY is less volatile compared to UNCHF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check UNCHF's competition here
PGENY vs SSDOF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SSDOF has a market cap of 8B. Regarding current trading prices, PGENY is priced at $2.53, while SSDOF trades at $20.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SSDOF's P/E ratio is -31.37. In terms of profitability, PGENY's ROE is +0.11%, compared to SSDOF's ROE of -0.07%. Regarding short-term risk, PGENY is less volatile compared to SSDOF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check SSDOF's competition here
PGENY vs SSDOY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SSDOY has a market cap of 7.5B. Regarding current trading prices, PGENY is priced at $2.53, while SSDOY trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SSDOY's P/E ratio is -30.23. In terms of profitability, PGENY's ROE is +0.11%, compared to SSDOY's ROE of -0.07%. Regarding short-term risk, PGENY is less volatile compared to SSDOY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check SSDOY's competition here
PGENY vs KCDMF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KCDMF has a market cap of 7.1B. Regarding current trading prices, PGENY is priced at $2.53, while KCDMF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KCDMF's P/E ratio is 16.79. In terms of profitability, PGENY's ROE is +0.11%, compared to KCDMF's ROE of +1.56%. Regarding short-term risk, PGENY is less volatile compared to KCDMF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check KCDMF's competition here
PGENY vs KCDMY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KCDMY has a market cap of 7B. Regarding current trading prices, PGENY is priced at $2.53, while KCDMY trades at $11.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KCDMY's P/E ratio is 16.51. In terms of profitability, PGENY's ROE is +0.11%, compared to KCDMY's ROE of +1.55%. Regarding short-term risk, PGENY is less volatile compared to KCDMY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check KCDMY's competition here
PGENY vs LCCTF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, LCCTF has a market cap of 6.6B. Regarding current trading prices, PGENY is priced at $2.53, while LCCTF trades at $4.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas LCCTF's P/E ratio is 63.57. In terms of profitability, PGENY's ROE is +0.11%, compared to LCCTF's ROE of +0.09%. Regarding short-term risk, PGENY is less volatile compared to LCCTF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check LCCTF's competition here
PGENY vs BICEY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, BICEY has a market cap of 5.2B. Regarding current trading prices, PGENY is priced at $2.53, while BICEY trades at $31.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas BICEY's P/E ratio is 12.88. In terms of profitability, PGENY's ROE is +0.11%, compared to BICEY's ROE of +0.05%. Regarding short-term risk, PGENY is less volatile compared to BICEY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check BICEY's competition here
PGENY vs UNLRY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, UNLRY has a market cap of 4.3B. Regarding current trading prices, PGENY is priced at $2.53, while UNLRY trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas UNLRY's P/E ratio is 20.64. In terms of profitability, PGENY's ROE is +0.11%, compared to UNLRY's ROE of +1.13%. Regarding short-term risk, PGENY is less volatile compared to UNLRY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check UNLRY's competition here
PGENY vs HEGIF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, HEGIF has a market cap of 4.2B. Regarding current trading prices, PGENY is priced at $2.53, while HEGIF trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas HEGIF's P/E ratio is 12.38. In terms of profitability, PGENY's ROE is +0.11%, compared to HEGIF's ROE of +0.11%. Regarding short-term risk, PGENY and HEGIF have similar daily volatility (0.00).Check HEGIF's competition here
PGENY vs HEGIY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, HEGIY has a market cap of 4.1B. Regarding current trading prices, PGENY is priced at $2.53, while HEGIY trades at $17.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas HEGIY's P/E ratio is 12.40. In terms of profitability, PGENY's ROE is +0.11%, compared to HEGIY's ROE of +0.07%. Regarding short-term risk, PGENY is less volatile compared to HEGIY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check HEGIY's competition here
PGENY vs NTCOY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, NTCOY has a market cap of 3.8B. Regarding current trading prices, PGENY is priced at $2.53, while NTCOY trades at $5.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas NTCOY's P/E ratio is -8.30. In terms of profitability, PGENY's ROE is +0.11%, compared to NTCOY's ROE of -0.15%. Regarding short-term risk, PGENY is less volatile compared to NTCOY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check NTCOY's competition here
PGENY vs UNLRF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, UNLRF has a market cap of 3.8B. Regarding current trading prices, PGENY is priced at $2.53, while UNLRF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas UNLRF's P/E ratio is 10.00. In terms of profitability, PGENY's ROE is +0.11%, compared to UNLRF's ROE of +2.22%. Regarding short-term risk, PGENY is less volatile compared to UNLRF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check UNLRF's competition here
PGENY vs VDAHF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, VDAHF has a market cap of 3.6B. Regarding current trading prices, PGENY is priced at $2.53, while VDAHF trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas VDAHF's P/E ratio is 99.00. In terms of profitability, PGENY's ROE is +0.11%, compared to VDAHF's ROE of +0.02%. Regarding short-term risk, PGENY and VDAHF have similar daily volatility (0.00).Check VDAHF's competition here
PGENY vs RPHCF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, RPHCF has a market cap of 3.4B. Regarding current trading prices, PGENY is priced at $2.53, while RPHCF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas RPHCF's P/E ratio is 15.51. In terms of profitability, PGENY's ROE is +0.11%, compared to RPHCF's ROE of +0.13%. Regarding short-term risk, PGENY and RPHCF have similar daily volatility (0.00).Check RPHCF's competition here
PGENY vs LIOPF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, LIOPF has a market cap of 3.2B. Regarding current trading prices, PGENY is priced at $2.53, while LIOPF trades at $11.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas LIOPF's P/E ratio is 18.27. In terms of profitability, PGENY's ROE is +0.11%, compared to LIOPF's ROE of +0.09%. Regarding short-term risk, PGENY and LIOPF have similar daily volatility (0.00).Check LIOPF's competition here
PGENY vs VDAHY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, VDAHY has a market cap of 3B. Regarding current trading prices, PGENY is priced at $2.53, while VDAHY trades at $21.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas VDAHY's P/E ratio is 108.35. In terms of profitability, PGENY's ROE is +0.11%, compared to VDAHY's ROE of +0.02%. Regarding short-term risk, PGENY and VDAHY have similar daily volatility (0.00).Check VDAHY's competition here
PGENY vs BICEF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, BICEF has a market cap of 2.6B. Regarding current trading prices, PGENY is priced at $2.53, while BICEF trades at $62.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas BICEF's P/E ratio is 12.44. In terms of profitability, PGENY's ROE is +0.11%, compared to BICEF's ROE of +0.05%. Regarding short-term risk, PGENY and BICEF have similar daily volatility (0.00).Check BICEF's competition here
PGENY vs KBYPF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KBYPF has a market cap of 2.5B. Regarding current trading prices, PGENY is priced at $2.53, while KBYPF trades at $34.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KBYPF's P/E ratio is 109.84. In terms of profitability, PGENY's ROE is +0.11%, compared to KBYPF's ROE of +0.02%. Regarding short-term risk, PGENY and KBYPF have similar daily volatility (0.00).Check KBYPF's competition here
PGENY vs FACYF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, FACYF has a market cap of 2.4B. Regarding current trading prices, PGENY is priced at $2.53, while FACYF trades at $17.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas FACYF's P/E ratio is 34.22. In terms of profitability, PGENY's ROE is +0.11%, compared to FACYF's ROE of +0.22%. Regarding short-term risk, PGENY and FACYF have similar daily volatility (0.00).Check FACYF's competition here
PGENY vs LIOPY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, LIOPY has a market cap of 2.3B. Regarding current trading prices, PGENY is priced at $2.53, while LIOPY trades at $16.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas LIOPY's P/E ratio is 22.16. In terms of profitability, PGENY's ROE is +0.11%, compared to LIOPY's ROE of +0.09%. Regarding short-term risk, PGENY and LIOPY have similar daily volatility (0.00).Check LIOPY's competition here
PGENY vs KSRYY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KSRYY has a market cap of 2B. Regarding current trading prices, PGENY is priced at $2.53, while KSRYY trades at $7.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KSRYY's P/E ratio is 21.09. In terms of profitability, PGENY's ROE is +0.11%, compared to KSRYY's ROE of +0.05%. Regarding short-term risk, PGENY and KSRYY have similar daily volatility (0.00).Check KSRYY's competition here
PGENY vs PORBF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, PORBF has a market cap of 1.9B. Regarding current trading prices, PGENY is priced at $2.53, while PORBF trades at $8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas PORBF's P/E ratio is 45.79. In terms of profitability, PGENY's ROE is +0.11%, compared to PORBF's ROE of +0.06%. Regarding short-term risk, PGENY and PORBF have similar daily volatility (0.00).Check PORBF's competition here
PGENY vs KOSCF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KOSCF has a market cap of 1.9B. Regarding current trading prices, PGENY is priced at $2.53, while KOSCF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KOSCF's P/E ratio is 19.76. In terms of profitability, PGENY's ROE is +0.11%, compared to KOSCF's ROE of +0.04%. Regarding short-term risk, PGENY and KOSCF have similar daily volatility (0.00).Check KOSCF's competition here
PGENY vs BLUMY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, BLUMY has a market cap of 1.9B. Regarding current trading prices, PGENY is priced at $2.53, while BLUMY trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas BLUMY's P/E ratio is -29.33. In terms of profitability, PGENY's ROE is +0.11%, compared to BLUMY's ROE of -0.06%. Regarding short-term risk, PGENY is less volatile compared to BLUMY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check BLUMY's competition here
PGENY vs MIOFF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, MIOFF has a market cap of 1.7B. Regarding current trading prices, PGENY is priced at $2.53, while MIOFF trades at $52.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas MIOFF's P/E ratio is 40.46. In terms of profitability, PGENY's ROE is +0.11%, compared to MIOFF's ROE of +0.07%. Regarding short-term risk, PGENY and MIOFF have similar daily volatility (0.00).Check MIOFF's competition here
PGENY vs PIGEF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, PIGEF has a market cap of 1.2B. Regarding current trading prices, PGENY is priced at $2.53, while PIGEF trades at $10.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas PIGEF's P/E ratio is 22.93. In terms of profitability, PGENY's ROE is +0.11%, compared to PIGEF's ROE of +0.11%. Regarding short-term risk, PGENY is less volatile compared to PIGEF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check PIGEF's competition here
PGENY vs SRTSF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SRTSF has a market cap of 996.3M. Regarding current trading prices, PGENY is priced at $2.53, while SRTSF trades at $15.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SRTSF's P/E ratio is 16.64. In terms of profitability, PGENY's ROE is +0.11%, compared to SRTSF's ROE of +0.14%. Regarding short-term risk, PGENY and SRTSF have similar daily volatility (0.00).Check SRTSF's competition here
PGENY vs ONXYY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, ONXYY has a market cap of 810.9M. Regarding current trading prices, PGENY is priced at $2.53, while ONXYY trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas ONXYY's P/E ratio is 20.83. In terms of profitability, PGENY's ROE is +0.11%, compared to ONXYY's ROE of -0.18%. Regarding short-term risk, PGENY and ONXYY have similar daily volatility (0.00).Check ONXYY's competition here
PGENY vs MDOMF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, MDOMF has a market cap of 722.2M. Regarding current trading prices, PGENY is priced at $2.53, while MDOMF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas MDOMF's P/E ratio is 57.14. In terms of profitability, PGENY's ROE is +0.11%, compared to MDOMF's ROE of +0.03%. Regarding short-term risk, PGENY and MDOMF have similar daily volatility (0.00).Check MDOMF's competition here
PGENY vs DUNIY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, DUNIY has a market cap of 691.8M. Regarding current trading prices, PGENY is priced at $2.53, while DUNIY trades at $29.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas DUNIY's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to DUNIY's ROE of +0.09%. Regarding short-term risk, PGENY and DUNIY have similar daily volatility (0.00).Check DUNIY's competition here
PGENY vs YAMNF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, YAMNF has a market cap of 464.9M. Regarding current trading prices, PGENY is priced at $2.53, while YAMNF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas YAMNF's P/E ratio is 8.37. In terms of profitability, PGENY's ROE is +0.11%, compared to YAMNF's ROE of -0.02%. Regarding short-term risk, PGENY and YAMNF have similar daily volatility (0.00).Check YAMNF's competition here
PGENY vs ONXXF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, ONXXF has a market cap of 418.9M. Regarding current trading prices, PGENY is priced at $2.53, while ONXXF trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas ONXXF's P/E ratio is 22.46. In terms of profitability, PGENY's ROE is +0.11%, compared to ONXXF's ROE of -0.18%. Regarding short-term risk, PGENY is less volatile compared to ONXXF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check ONXXF's competition here
PGENY vs MCBRF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, MCBRF has a market cap of 358M. Regarding current trading prices, PGENY is priced at $2.53, while MCBRF trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas MCBRF's P/E ratio is 9.00. In terms of profitability, PGENY's ROE is +0.11%, compared to MCBRF's ROE of +0.31%. Regarding short-term risk, PGENY and MCBRF have similar daily volatility (0.00).Check MCBRF's competition here
PGENY vs PZCUY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, PZCUY has a market cap of 316.7M. Regarding current trading prices, PGENY is priced at $2.53, while PZCUY trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas PZCUY's P/E ratio is -37.75. In terms of profitability, PGENY's ROE is +0.11%, compared to PZCUY's ROE of -0.02%. Regarding short-term risk, PGENY is less volatile compared to PZCUY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check PZCUY's competition here
PGENY vs WPNTF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, WPNTF has a market cap of 269.8M. Regarding current trading prices, PGENY is priced at $2.53, while WPNTF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas WPNTF's P/E ratio is 12.85. In terms of profitability, PGENY's ROE is +0.11%, compared to WPNTF's ROE of +0.21%. Regarding short-term risk, PGENY is less volatile compared to WPNTF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check WPNTF's competition here
PGENY vs OLVI Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, OLVI has a market cap of 241.4M. Regarding current trading prices, PGENY is priced at $2.53, while OLVI trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas OLVI's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to OLVI's ROE of -3.12%. Regarding short-term risk, PGENY is less volatile compared to OLVI. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check OLVI's competition here
PGENY vs KITAF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KITAF has a market cap of 135.3M. Regarding current trading prices, PGENY is priced at $2.53, while KITAF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KITAF's P/E ratio is 19.41. In terms of profitability, PGENY's ROE is +0.11%, compared to KITAF's ROE of +0.09%. Regarding short-term risk, PGENY is less volatile compared to KITAF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check KITAF's competition here
PGENY vs NBBTF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, NBBTF has a market cap of 118.1M. Regarding current trading prices, PGENY is priced at $2.53, while NBBTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas NBBTF's P/E ratio is -5.90. In terms of profitability, PGENY's ROE is +0.11%, compared to NBBTF's ROE of +0.02%. Regarding short-term risk, PGENY and NBBTF have similar daily volatility (0.00).Check NBBTF's competition here
PGENY vs UNHLF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, UNHLF has a market cap of 101.9M. Regarding current trading prices, PGENY is priced at $2.53, while UNHLF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas UNHLF's P/E ratio is -4.30. In terms of profitability, PGENY's ROE is +0.11%, compared to UNHLF's ROE of -0.11%. Regarding short-term risk, PGENY and UNHLF have similar daily volatility (0.00).Check UNHLF's competition here
PGENY vs KPTSF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KPTSF has a market cap of 79.6M. Regarding current trading prices, PGENY is priced at $2.53, while KPTSF trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KPTSF's P/E ratio is 12.82. In terms of profitability, PGENY's ROE is +0.11%, compared to KPTSF's ROE of +0.06%. Regarding short-term risk, PGENY and KPTSF have similar daily volatility (0.00).Check KPTSF's competition here
PGENY vs RVIV Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, RVIV has a market cap of 79M. Regarding current trading prices, PGENY is priced at $2.53, while RVIV trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas RVIV's P/E ratio is 64.29. In terms of profitability, PGENY's ROE is +0.11%, compared to RVIV's ROE of +0.02%. Regarding short-term risk, PGENY is less volatile compared to RVIV. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check RVIV's competition here
PGENY vs ZOONF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, ZOONF has a market cap of 16.2M. Regarding current trading prices, PGENY is priced at $2.53, while ZOONF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas ZOONF's P/E ratio is -4.00. In terms of profitability, PGENY's ROE is +0.11%, compared to ZOONF's ROE of -0.98%. Regarding short-term risk, PGENY is less volatile compared to ZOONF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check ZOONF's competition here
PGENY vs PURE Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, PURE has a market cap of 9.2M. Regarding current trading prices, PGENY is priced at $2.53, while PURE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas PURE's P/E ratio is -8.20. In terms of profitability, PGENY's ROE is +0.11%, compared to PURE's ROE of +0.46%. Regarding short-term risk, PGENY is less volatile compared to PURE. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check PURE's competition here
PGENY vs ADTI Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, ADTI has a market cap of 8.1M. Regarding current trading prices, PGENY is priced at $2.53, while ADTI trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas ADTI's P/E ratio is -0.92. In terms of profitability, PGENY's ROE is +0.11%, compared to ADTI's ROE of +0.91%. Regarding short-term risk, PGENY and ADTI have similar daily volatility (0.00).Check ADTI's competition here
PGENY vs MIMNF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, MIMNF has a market cap of 6.8M. Regarding current trading prices, PGENY is priced at $2.53, while MIMNF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas MIMNF's P/E ratio is 17.10. In terms of profitability, PGENY's ROE is +0.11%, compared to MIMNF's ROE of N/A. Regarding short-term risk, PGENY and MIMNF have similar daily volatility (0.00).Check MIMNF's competition here
PGENY vs DQWS Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, DQWS has a market cap of 6.4M. Regarding current trading prices, PGENY is priced at $2.53, while DQWS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas DQWS's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to DQWS's ROE of -0.25%. Regarding short-term risk, PGENY is less volatile compared to DQWS. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check DQWS's competition here
PGENY vs NUVI Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, NUVI has a market cap of 6M. Regarding current trading prices, PGENY is priced at $2.53, while NUVI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas NUVI's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to NUVI's ROE of +0.01%. Regarding short-term risk, PGENY is less volatile compared to NUVI. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check NUVI's competition here
PGENY vs PRFUF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, PRFUF has a market cap of 5.5M. Regarding current trading prices, PGENY is priced at $2.53, while PRFUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas PRFUF's P/E ratio is -0.25. In terms of profitability, PGENY's ROE is +0.11%, compared to PRFUF's ROE of -0.04%. Regarding short-term risk, PGENY is less volatile compared to PRFUF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check PRFUF's competition here
PGENY vs MAVBF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, MAVBF has a market cap of 4.8M. Regarding current trading prices, PGENY is priced at $2.53, while MAVBF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas MAVBF's P/E ratio is -0.03. In terms of profitability, PGENY's ROE is +0.11%, compared to MAVBF's ROE of -2.47%. Regarding short-term risk, PGENY and MAVBF have similar daily volatility (0.00).Check MAVBF's competition here
PGENY vs REVRQ Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, REVRQ has a market cap of 3.8M. Regarding current trading prices, PGENY is priced at $2.53, while REVRQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas REVRQ's P/E ratio is -0.01. In terms of profitability, PGENY's ROE is +0.11%, compared to REVRQ's ROE of +0.89%. Regarding short-term risk, PGENY and REVRQ have similar daily volatility (0.00).Check REVRQ's competition here
PGENY vs CAWW Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, CAWW has a market cap of 3.6M. Regarding current trading prices, PGENY is priced at $2.53, while CAWW trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas CAWW's P/E ratio is -4.70. In terms of profitability, PGENY's ROE is +0.11%, compared to CAWW's ROE of -0.23%. Regarding short-term risk, PGENY and CAWW have similar daily volatility (0.00).Check CAWW's competition here
PGENY vs CLGOF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, CLGOF has a market cap of 3.4M. Regarding current trading prices, PGENY is priced at $2.53, while CLGOF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas CLGOF's P/E ratio is -2.30. In terms of profitability, PGENY's ROE is +0.11%, compared to CLGOF's ROE of +1.48%. Regarding short-term risk, PGENY and CLGOF have similar daily volatility (0.00).Check CLGOF's competition here
PGENY vs SNBH Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SNBH has a market cap of 2.3M. Regarding current trading prices, PGENY is priced at $2.53, while SNBH trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SNBH's P/E ratio is -1.55. In terms of profitability, PGENY's ROE is +0.11%, compared to SNBH's ROE of +0.69%. Regarding short-term risk, PGENY is less volatile compared to SNBH. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check SNBH's competition here
PGENY vs SKVI Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SKVI has a market cap of 1.1M. Regarding current trading prices, PGENY is priced at $2.53, while SKVI trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SKVI's P/E ratio is -3.00. In terms of profitability, PGENY's ROE is +0.11%, compared to SKVI's ROE of +0.05%. Regarding short-term risk, PGENY and SKVI have similar daily volatility (0.00).Check SKVI's competition here
PGENY vs SLGD Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SLGD has a market cap of 812.9K. Regarding current trading prices, PGENY is priced at $2.53, while SLGD trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SLGD's P/E ratio is -0.19. In terms of profitability, PGENY's ROE is +0.11%, compared to SLGD's ROE of -0.11%. Regarding short-term risk, PGENY is less volatile compared to SLGD. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check SLGD's competition here
PGENY vs SPCO Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SPCO has a market cap of 777K. Regarding current trading prices, PGENY is priced at $2.53, while SPCO trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SPCO's P/E ratio is -19.19. In terms of profitability, PGENY's ROE is +0.11%, compared to SPCO's ROE of -0.01%. Regarding short-term risk, PGENY is less volatile compared to SPCO. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check SPCO's competition here
PGENY vs WNBD Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, WNBD has a market cap of 732.9K. Regarding current trading prices, PGENY is priced at $2.53, while WNBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas WNBD's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to WNBD's ROE of +0.02%. Regarding short-term risk, PGENY and WNBD have similar daily volatility (0.00).Check WNBD's competition here
PGENY vs PYCT Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, PYCT has a market cap of 553.7K. Regarding current trading prices, PGENY is priced at $2.53, while PYCT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas PYCT's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to PYCT's ROE of +0.64%. Regarding short-term risk, PGENY is less volatile compared to PYCT. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check PYCT's competition here
PGENY vs NASO Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, NASO has a market cap of 446.7K. Regarding current trading prices, PGENY is priced at $2.53, while NASO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas NASO's P/E ratio is -50.50. In terms of profitability, PGENY's ROE is +0.11%, compared to NASO's ROE of +1.01%. Regarding short-term risk, PGENY is less volatile compared to NASO. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check NASO's competition here
PGENY vs PHLI Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, PHLI has a market cap of 438.3K. Regarding current trading prices, PGENY is priced at $2.53, while PHLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas PHLI's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to PHLI's ROE of -0.54%. Regarding short-term risk, PGENY is less volatile compared to PHLI. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check PHLI's competition here
PGENY vs HRSR Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, HRSR has a market cap of 177.6K. Regarding current trading prices, PGENY is priced at $2.53, while HRSR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas HRSR's P/E ratio is -0.02. In terms of profitability, PGENY's ROE is +0.11%, compared to HRSR's ROE of +65.69%. Regarding short-term risk, PGENY is less volatile compared to HRSR. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check HRSR's competition here
PGENY vs NUUU Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, NUUU has a market cap of 117.8K. Regarding current trading prices, PGENY is priced at $2.53, while NUUU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas NUUU's P/E ratio is -0.01. In terms of profitability, PGENY's ROE is +0.11%, compared to NUUU's ROE of +0.36%. Regarding short-term risk, PGENY and NUUU have similar daily volatility (0.00).Check NUUU's competition here
PGENY vs SNST Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SNST has a market cap of 106.4K. Regarding current trading prices, PGENY is priced at $2.53, while SNST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SNST's P/E ratio is -0.01. In terms of profitability, PGENY's ROE is +0.11%, compared to SNST's ROE of -1.59%. Regarding short-term risk, PGENY is less volatile compared to SNST. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check SNST's competition here
PGENY vs EESO Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, EESO has a market cap of 72.9K. Regarding current trading prices, PGENY is priced at $2.53, while EESO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas EESO's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to EESO's ROE of N/A. Regarding short-term risk, PGENY is less volatile compared to EESO. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check EESO's competition here
PGENY vs KPOC Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, KPOC has a market cap of 68.7K. Regarding current trading prices, PGENY is priced at $2.53, while KPOC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas KPOC's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to KPOC's ROE of +0.01%. Regarding short-term risk, PGENY is less volatile compared to KPOC. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check KPOC's competition here
PGENY vs TVOG Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, TVOG has a market cap of 63.9K. Regarding current trading prices, PGENY is priced at $2.53, while TVOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas TVOG's P/E ratio is -0.03. In terms of profitability, PGENY's ROE is +0.11%, compared to TVOG's ROE of +0.78%. Regarding short-term risk, PGENY and TVOG have similar daily volatility (0.00).Check TVOG's competition here
PGENY vs EOSS Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, EOSS has a market cap of 60.5K. Regarding current trading prices, PGENY is priced at $2.53, while EOSS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas EOSS's P/E ratio is -0.01. In terms of profitability, PGENY's ROE is +0.11%, compared to EOSS's ROE of +0.64%. Regarding short-term risk, PGENY is less volatile compared to EOSS. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check EOSS's competition here
PGENY vs QNTA Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, QNTA has a market cap of 40.7K. Regarding current trading prices, PGENY is priced at $2.53, while QNTA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas QNTA's P/E ratio is 0.01. In terms of profitability, PGENY's ROE is +0.11%, compared to QNTA's ROE of +2.75%. Regarding short-term risk, PGENY and QNTA have similar daily volatility (0.00).Check QNTA's competition here
PGENY vs GRBG Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, GRBG has a market cap of 39K. Regarding current trading prices, PGENY is priced at $2.53, while GRBG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas GRBG's P/E ratio is 0.10. In terms of profitability, PGENY's ROE is +0.11%, compared to GRBG's ROE of N/A. Regarding short-term risk, PGENY and GRBG have similar daily volatility (0.00).Check GRBG's competition here
PGENY vs JOEY Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, JOEY has a market cap of 37.7K. Regarding current trading prices, PGENY is priced at $2.53, while JOEY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas JOEY's P/E ratio is 0.01. In terms of profitability, PGENY's ROE is +0.11%, compared to JOEY's ROE of +0.19%. Regarding short-term risk, PGENY is less volatile compared to JOEY. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check JOEY's competition here
PGENY vs EMPO Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, EMPO has a market cap of 25.1K. Regarding current trading prices, PGENY is priced at $2.53, while EMPO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas EMPO's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to EMPO's ROE of -0.37%. Regarding short-term risk, PGENY is less volatile compared to EMPO. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check EMPO's competition here
PGENY vs HPTN Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, HPTN has a market cap of 22.7K. Regarding current trading prices, PGENY is priced at $2.53, while HPTN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas HPTN's P/E ratio is -0.04. In terms of profitability, PGENY's ROE is +0.11%, compared to HPTN's ROE of -1.08%. Regarding short-term risk, PGENY is less volatile compared to HPTN. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check HPTN's competition here
PGENY vs INBI Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, INBI has a market cap of 18.1K. Regarding current trading prices, PGENY is priced at $2.53, while INBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas INBI's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to INBI's ROE of +0.54%. Regarding short-term risk, PGENY is less volatile compared to INBI. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check INBI's competition here
PGENY vs GYSN Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, GYSN has a market cap of 14K. Regarding current trading prices, PGENY is priced at $2.53, while GYSN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas GYSN's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to GYSN's ROE of +0.14%. Regarding short-term risk, PGENY and GYSN have similar daily volatility (0.00).Check GYSN's competition here
PGENY vs BRSHF Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, BRSHF has a market cap of 13.4K. Regarding current trading prices, PGENY is priced at $2.53, while BRSHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas BRSHF's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to BRSHF's ROE of +14.14%. Regarding short-term risk, PGENY is less volatile compared to BRSHF. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check BRSHF's competition here
PGENY vs ZRVT Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, ZRVT has a market cap of 13K. Regarding current trading prices, PGENY is priced at $2.53, while ZRVT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas ZRVT's P/E ratio is -0.02. In terms of profitability, PGENY's ROE is +0.11%, compared to ZRVT's ROE of +0.04%. Regarding short-term risk, PGENY and ZRVT have similar daily volatility (0.00).Check ZRVT's competition here
PGENY vs SYHO Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SYHO has a market cap of 7.9K. Regarding current trading prices, PGENY is priced at $2.53, while SYHO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SYHO's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to SYHO's ROE of N/A. Regarding short-term risk, PGENY and SYHO have similar daily volatility (0.00).Check SYHO's competition here
PGENY vs BMXC Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, BMXC has a market cap of 6.8K. Regarding current trading prices, PGENY is priced at $2.53, while BMXC trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas BMXC's P/E ratio is -0.01. In terms of profitability, PGENY's ROE is +0.11%, compared to BMXC's ROE of +1.33%. Regarding short-term risk, PGENY is less volatile compared to BMXC. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check BMXC's competition here
PGENY vs BEUT Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, BEUT has a market cap of 3.2K. Regarding current trading prices, PGENY is priced at $2.53, while BEUT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas BEUT's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to BEUT's ROE of +1.96%. Regarding short-term risk, PGENY and BEUT have similar daily volatility (0.00).Check BEUT's competition here
PGENY vs NCDP Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, NCDP has a market cap of 1.8K. Regarding current trading prices, PGENY is priced at $2.53, while NCDP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas NCDP's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to NCDP's ROE of N/A. Regarding short-term risk, PGENY and NCDP have similar daily volatility (0.00).Check NCDP's competition here
PGENY vs MDAV Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, MDAV has a market cap of 1.4K. Regarding current trading prices, PGENY is priced at $2.53, while MDAV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas MDAV's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to MDAV's ROE of -1.64%. Regarding short-term risk, PGENY and MDAV have similar daily volatility (0.00).Check MDAV's competition here
PGENY vs RBCL Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, RBCL has a market cap of 1.3K. Regarding current trading prices, PGENY is priced at $2.53, while RBCL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas RBCL's P/E ratio is -0.03. In terms of profitability, PGENY's ROE is +0.11%, compared to RBCL's ROE of -0.10%. Regarding short-term risk, PGENY is less volatile compared to RBCL. This indicates potentially lower risk in terms of short-term price fluctuations for PGENY.Check RBCL's competition here
PGENY vs PCGR Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, PCGR has a market cap of 785. Regarding current trading prices, PGENY is priced at $2.53, while PCGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas PCGR's P/E ratio is -0.01. In terms of profitability, PGENY's ROE is +0.11%, compared to PCGR's ROE of -0.18%. Regarding short-term risk, PGENY and PCGR have similar daily volatility (0.00).Check PCGR's competition here
PGENY vs SOYO Comparison March 2026
PGENY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGENY stands at 1.2B. In comparison, SOYO has a market cap of 61. Regarding current trading prices, PGENY is priced at $2.53, while SOYO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGENY currently has a P/E ratio of 23.00, whereas SOYO's P/E ratio is N/A. In terms of profitability, PGENY's ROE is +0.11%, compared to SOYO's ROE of N/A. Regarding short-term risk, PGENY and SOYO have similar daily volatility (0.00).Check SOYO's competition here